
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
Mossner, E., Brunker, P., Moser, S., Puntener, U., Schmidt, C., Herter, S., Grau, R., Gerdes, C., Nopora, A., van Puijenbroek, E., Ferrara, C., Sondermann, P., Jager, C., Strein, P., Fertig, G., FriesVolume:
115
Langue:
english
Journal:
Blood
DOI:
10.1182/blood-2009-06-225979
Date:
June, 2010
Fichier:
PDF, 1.30 MB
english, 2010